Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Dixon

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Quarterly Journal of Experimental Psychology (2006)|July 27, 2016
Simulation-based mentalizing generates a "proxy" self-reference effect in memoryKevin Allan, Suzannah Morson, Susan Dixon, et al.
Pediatric Pulmonology|February 18, 2004
Risk factors for an intensive care unit admission in children with asthmaYvonne Belessis, Susan Dixon, Amanda Thomsen, et al.
Integrative Cancer Therapies|December 1, 2007
Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycosideRobert A Newman, Yasuko Kondo, Tomohisa Yokoyama, et al.
Molecular Cancer Therapeutics|August 13, 2009
Oleandrin-mediated inhibition of human tumor cell proliferation: importance of Na,K-ATPase alpha subunits as drug targetsPeiying Yang, David G Menter, Carrie Cartwright, et al.
Hepatology International|October 3, 2025
Immunomodulation by bepirovirsen may induce killing of infected hepatocytes (B-Together study)Shilpy Joshi, Johannes M Freudenberg, Jennifer M Singh, et al.
Journal of Experimental Therapeutics & Oncology|March 15, 2006
Oleandrin-mediated oxidative stress in human melanoma cellsRobert A Newman, Peiying Yang, Walter N Hittelman, et al.
Hepatology International|April 13, 2011
Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistanceRobert P Perrillo, Hie-Won Hann, Eugene Schiff, et al.
Journal of Hepatology|August 30, 2024
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis BMaria Buti, Jeong Heo, Yasuhito Tanaka, et al.
Nature|July 27, 2018
Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasisSusan Wyllie, Michael Thomas, Stephen Patterson, et al.
Nature|July 4, 2023
Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasisSusan Wyllie, Michael Thomas, Stephen Patterson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Quarterly Journal of Experimental Psychology (2006)|July 27, 2016
Simulation-based mentalizing generates a "proxy" self-reference effect in memoryKevin Allan, Suzannah Morson, Susan Dixon, et al.
Pediatric Pulmonology|February 18, 2004
Risk factors for an intensive care unit admission in children with asthmaYvonne Belessis, Susan Dixon, Amanda Thomsen, et al.
Integrative Cancer Therapies|December 1, 2007
Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycosideRobert A Newman, Yasuko Kondo, Tomohisa Yokoyama, et al.
Molecular Cancer Therapeutics|August 13, 2009
Oleandrin-mediated inhibition of human tumor cell proliferation: importance of Na,K-ATPase alpha subunits as drug targetsPeiying Yang, David G Menter, Carrie Cartwright, et al.
Hepatology International|October 3, 2025
Immunomodulation by bepirovirsen may induce killing of infected hepatocytes (B-Together study)Shilpy Joshi, Johannes M Freudenberg, Jennifer M Singh, et al.
Journal of Experimental Therapeutics & Oncology|March 15, 2006
Oleandrin-mediated oxidative stress in human melanoma cellsRobert A Newman, Peiying Yang, Walter N Hittelman, et al.
Hepatology International|April 13, 2011
Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistanceRobert P Perrillo, Hie-Won Hann, Eugene Schiff, et al.
Journal of Hepatology|August 30, 2024
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis BMaria Buti, Jeong Heo, Yasuhito Tanaka, et al.
Nature|July 27, 2018
Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasisSusan Wyllie, Michael Thomas, Stephen Patterson, et al.
Nature|July 4, 2023
Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasisSusan Wyllie, Michael Thomas, Stephen Patterson, et al.
Pageof 1